i-sense researcher Natascha Kappeler will present her work on nanomechanical detection of antimicrobial resistance at this Thursday's LGC and Great Ormond Street Hospital workshop `"Clinical application of advanced molecular methods".
Venue: LGC, Queens Road, Teddington, Middlesex, TW11 0LY
Molecular approaches such as next generation sequencing (NGS) and PCR are increasingly being used to detect, quantify and characterise microbial organisms in human disease.
While such approaches have considerable potential, many users are unsure how to best apply them in a manner that will ensure best practice. Additionally, the rapid development of NGS in particular, but also PCR, means that users may be unsure of what is available when assessing equipment, chemistry, calibration strategy and other considerations.
This workshop, which is being co-organised by Great Ormond Street Hospital and LGC, will focus on the best practice application of advanced molecular methods on human infectious disease. Delegates will be provided with an overview of current methods and potential applications, as well as some of the current challenges faced by those who are applying these technologies to the study of infectious diseases. In addition methods for improving standardisation will be discussed
Natascha is a postdoctoral researcher associate working on bacterial infections for i-sense. She joined i-sense earlier this year after receiving her PhD in Medical Nanotechnology from UCL. Her research interests include multidisciplinary approaches for the diagnosis and monitoring of infectious diseases, particularly influenza and bacterial infections. Furthermore, she is interested in therapeutic drug monitoring and antibiotic stewardship and holds a patent on this with Sphere Medical.